Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 2Phase NA 1

Status

Terminated 2Unknown 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Classical hematology 4Thoracic 1

Conditions

Venous Thromboembolism 4Venous Thrombosis 2Thromboembolism 2Lung Neoplasms 2Pulmonary Embolism 1Pancreatic Neoplasms 1Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Dalteparin 8apixaban 6Rivaroxaban 6Heparin, Low-Molecular-Weight 5Tinzaparin 4Enoxaparin 4bemiparin 2abelacimab 2Warfarin 2MAA868 2Aspirin 2reviparin 1isoquercitrin 1edoxaban 1certoparin 1betrixaban 1argatroban 1acarboxyprothrombin 1Phenprocoumon 1Nadroparin 1N(4)-oleylcytosine arabinoside 1Dabigatran 1Acenocoumarol 1AVE 5026 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Venous Thromboembolism × Tinzaparin × Clear all
NCT01130025 2025-02-24

Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer

LEO Pharma

Phase 3 Completed
900 enrolled
Classical hematology

Venous Thromboembolism

NCT03090880 2022-11-17

PROVE

Assistance Publique - Hôpitaux de Paris

Phase 3 Terminated
59 enrolled
Classical hematologyThoracic

Lung Neoplasms, Venous Thromboembolism

NCT03240120 2019-04-17

A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism

The University of Hong Kong

Phase 3 Unknown
99 enrolled
Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT01164046 2014-12-03

Longheva

University Medical Center Groningen

Phase 3 Terminated
56 enrolled
Classical hematology

Neoplasms, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡